000143386 001__ 143386
000143386 005__ 20240229112551.0
000143386 0247_ $$2doi$$a10.1093/carcin/bgz059
000143386 0247_ $$2pmid$$apmid:30874287
000143386 0247_ $$2ISSN$$a0143-3334
000143386 0247_ $$2ISSN$$a1460-2180
000143386 0247_ $$2altmetric$$aaltmetric:74131331
000143386 037__ $$aDKFZ-2019-00974
000143386 041__ $$aeng
000143386 082__ $$a610
000143386 1001_ $$0P:(DE-He78)df8163feee808fc71aba915e4651ba8c$$aSrinivas, Nalini$$b0$$eFirst author$$udkfz
000143386 245__ $$aTelomere length, arsenic exposure and risk of basal cell carcinoma of skin.
000143386 260__ $$aOxford$$bOxford Univ. Press$$c2019
000143386 3367_ $$2DRIVER$$aarticle
000143386 3367_ $$2DataCite$$aOutput Types/Journal article
000143386 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1634731101_16360
000143386 3367_ $$2BibTeX$$aARTICLE
000143386 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143386 3367_ $$00$$2EndNote$$aJournal Article
000143386 520__ $$aTelomere length per se a heritable trait has been reported to be associated with different diseases including cancers. In this study based on arsenic exposed 528 cases with basal cell carcinoma of skin (BCC) and 533 healthy controls we investigated effect of telomere length, measured by real-time PCR, on the disease risk. We observed a statistically significant association between decreased telomere length and increased BCC risk (OR = 5.92, 95% CI = 3.92-9.01, P<0.0001). Due to confounder effect of arsenic exposure, in a two-sample Mendelian randomization (MR), telomere-length associated single nucleotide polymorphisms as instrument variables violated valid assumptions; however, one-sample MR adjusted for arsenic exposure indicated an increased risk of BCC with short telomeres. The interaction between arsenic exposure and telomere length on BCC risk was statistically significant (P = 0.02). Within each tertile based on arsenic exposure, the individuals with shorter telomeres were at an increased risk of BCC, with highest risk being in the highest exposed group (OR = 16.13, 95% CI = 6.71-40.00, P<0.0001); followed by those in medium exposure group and low exposure group. The combined effect of highest arsenic exposure and shortest telomeres on BCC risk (OR = 10.56, 95% CI = 5.14-21.70) showed a statistically significant departure from additivity (interaction constant ratio 6.56, P = 0.03). Our results show that in the presence of arsenic exposure, decreased telomere length predisposes individuals to increased risk of BCC, with the effect being synergistic in individuals with highest arsenic exposure and shortest telomeres.
000143386 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000143386 588__ $$aDataset connected to CrossRef, PubMed,
000143386 7001_ $$0P:(DE-HGF)0$$aRachakonda, Sivaramakrishna$$b1
000143386 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b2$$udkfz
000143386 7001_ $$aCalderazzo, Silvia$$b3
000143386 7001_ $$aRudnai, Peter$$b4
000143386 7001_ $$aGurzau, Eugen$$b5
000143386 7001_ $$aKoppova, Kvetoslava$$b6
000143386 7001_ $$aFletcher, Tony$$b7
000143386 7001_ $$0P:(DE-He78)9a9af43c15771eaf3b2db8bb28a2829d$$aKumar, Rajiv$$b8$$eLast author$$udkfz
000143386 773__ $$0PERI:(DE-600)1474206-8$$a10.1093/carcin/bgz059$$n6$$p715-723$$tCarcinogenesis$$v40$$x1460-2180$$y2019
000143386 909CO $$ooai:inrepo02.dkfz.de:143386$$pVDB
000143386 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)df8163feee808fc71aba915e4651ba8c$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000143386 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000143386 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143386 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9a9af43c15771eaf3b2db8bb28a2829d$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000143386 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000143386 9141_ $$y2019
000143386 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000143386 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143386 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143386 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143386 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000143386 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCARCINOGENESIS : 2017
000143386 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000143386 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000143386 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143386 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143386 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143386 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143386 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000143386 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143386 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCARCINOGENESIS : 2017
000143386 9201_ $$0I:(DE-He78)C050-20160331$$kC050$$lMolekular-Genetische Epidemiologie$$x0
000143386 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000143386 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000143386 980__ $$ajournal
000143386 980__ $$aVDB
000143386 980__ $$aI:(DE-He78)C050-20160331
000143386 980__ $$aI:(DE-He78)C060-20160331
000143386 980__ $$aI:(DE-He78)L101-20160331
000143386 980__ $$aUNRESTRICTED